SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-008088
Filing Date
2022-02-28
Accepted
2022-02-28 16:37:44
Documents
1
Period of Report
2022-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4126
  Complete submission text file 0000899243-22-008088.txt   5496
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

IRS No.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address
Lee John Jui-Jen (Reporting) CIK: 0001844264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40030 | Film No.: 22690426